Key personnel with a financial conflict of interest:
Nicholas Cosford, Ph.D.
Principal Investigator on grants R43 MH122063, U01 DA051077
Equity Interest (non-publicly traded entity): Camino Pharma LLC
Value cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Equity Interest (non-publicly traded entity): Cosford Consulting, Inc.
Value cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Andrei Osterman, Ph.D.
Principal Investigator on grant R01 DK030292
Equity Interest (non-publicly traded entity): Phenobiome, Inc.
Value cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
